Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 28, Issue 12, Pages 1829-1833
Publisher
Wiley
Online
2013-07-05
DOI
10.1111/jgh.12324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
- (2012) W. Reinisch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population
- (2012) Christina Ha et al. Clinical Gastroenterology and Hepatology
- Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
- (2011) Matthias Jürgens et al. Clinical Gastroenterology and Hepatology
- Safety of infliximab in 10 years of clinical practice
- (2011) Sarah OʼDonnell et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
- (2011) Jean Frédéric Colombel et al. GASTROENTEROLOGY
- Genetics of inflammatory bowel disease in Asia: Systematic review and meta-analysis
- (2011) Siew C. Ng et al. INFLAMMATORY BOWEL DISEASES
- Infliximab or cyclosporine for acute severe ulcerative colitis: A retrospective analysis
- (2011) Kathryn E Dean et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization
- (2010) Abderrahim Oussalah et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Disease Activity, ANCA and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis
- (2010) Matthias Jürgens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines
- (2010) Andrea Walch et al. Journal of Crohns & Colitis
- Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals
- (2010) Christian Mortensen et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease
- (2008) R. PANACCIONE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
- (2008) M Henriksen et al. GUT
- European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
- (2008) E.F. Stange et al. Journal of Crohns & Colitis
- Long-term outcome after infliximab for refractory ulcerative colitis
- (2008) Marc Ferrante et al. Journal of Crohns & Colitis
- Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID study
- (2007) Suk-Kyun Yang et al. INFLAMMATORY BOWEL DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation